PharmaRadar360

PharmaRadar360

🇺🇸·15h agoRegulatory

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

The Drug Enforcement Administration proposes placing five tryptamine hallucinogens, 4-hydroxy-N,N-di...

Publisher

F
Federal Register

USA

This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Federal Register
Region
USA
Scope
Regulatory
Published
September 23, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

The Drug Enforcement Administration proposes placing five tryptamine hallucinogens, 4-hydroxy-N,N-di...

Source route

Continue on federalregister.gov

Leave the platform to read the original full article on the publisher site.

Source: Federal Register

Scope: Regulatory

Open original article
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I | PharmaRadar360